|
Ultrasound Diagnostic for Oncology
Breast imaging is one of the fastest growing applications of ultrasound. GE Healthcare is the world’s leading provider of ultrasound technology,
including the high-performance LOGIQ 9, LOGIQ 7 and Voluson systems. Their superb image quality displays the detail resolution and tissue contrast differences that are critical to support the early detection, visualization and assessment of breast disease.
|
|
Products and Applications
|
GE is delivering a new age of ultrasound technology called Volume Ultrasound by combining the industry’s most
advanced system platforms, (LOGIQ and Voluson) multi-dimensional image applications and new 4D and Matrix array technologies.
|
Features for Oncology
|
Biopsy. Ultrasound is the primary modality for image guided biopsy procedures. With GE ultrasound, clinicians can easily align the needle position in real time to
biopsy breast lesions with more precision .
|
Real-time volume acquisition
|
GE’s patented Volume Contrast Imaging provides a homogenous, contrastrich image that allows precise
assessment of breast lesion size and clear visualization of the internal structures, enabling clinicians to identify subtle changes in adjacent structures.
|
Raw Data
|
GE’s exclusive ability to capture Raw Data allows a virtual rescan of the patient at any time after the study, both on the scanner as well as on a remote workstation. Raw Data, along with volume imaging protocols, can significantly increase productivity and improve diagnostic confidence.
|
Volume Calculation II (VOCAL II)
|
VOCAL II increases the speed and accuracy of volume assessments by automatically calculating volumes based on a quick fingertip tracing of the region of interest.
It allows you to measure and monitor the size of the lesions throughout the course of treatment.
|
|
|